Clinical Trial Update: A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating Lifileucel (tumor-infiltrating lymphocytes) in adults with advanced endometrial cancer; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Lifileucel (autologous tumor-infiltrating lymphocytes (TIL) therapy)

Snippet

Sponsor: Iovance Biotherapeutics, Inc. | Conditions: Endometrial Cancer | Phase 2 | Status: RECRUITING